Headquarters
425 PONTIUS AVE N STE 470, SEATTLE, WA 98109-5474, US
SEATTLE, WA, US
From the company
Immunexpress is a privately-owned molecular diagnostic company founded in Australia, with offices in Seattle, USA, and Brisbane, Australia. It develops and commercializes SeptiCyte® technology, which rapidly detects sepsis by analyzing a patient's immune response (host response) rather than pathogens. Its SeptiCyte® RAPID cartridge, compatible with the Biocartis Idylla™ platform, produces clinically actionable results in one hour.
425 PONTIUS AVE N STE 470, SEATTLE, WA 98109-5474, US
Quantities, certifications, and timing.